Investors taking initial positions during the offering are far better than those who bought an held in the mid range price of 10/12 as you can see, although cost averaging can lower your average pps. If they nail the science on the covid vaccine, i would say a price target of 9/10 is fair based on average sales, imo
Market Data 
Markets 
AI
